The 16th World Congress of the International Neuromodulation Society (INS) took place in Vancouver, Canada, 11-16 May, drawing over 1,200 experts from 57 countries. This major event in the field of neuromodulation not only advanced scientific and medical knowledge but also featured a special initiative aimed at patients and their families.
The congress, organised in collaboration with the Canadian Neuromodulation Society and global PCO, Kenes Group, brought together scientists, researchers, engineers, device developers, and healthcare providers. The attendees represented various regions including North America, Western Europe, East Asia, and more, highlighting the global importance of neuromodulation in advancing patient care.
A comprehensive scientific programme
The event showcased an extensive programme. Dr. Konstantin Slavin, the scientific programme committee chair and president-elect of the INS, emphasised the focus on pain management, movement disorders, psychiatric conditions, and epilepsy. Dr Marc Russo, the INS President, introduced a new stream of neuropsychiatry alongside traditional topics, enhancing the congress’s scientific value.
Discussions included the latest research on brain-machine interfaces, the role of big data and AI, and emerging technologies for pain management and mental health. With 135 abstracts submitted, 171 experts presenting, and 366 research posters displayed, the congress provided a platform for sharing groundbreaking findings and innovations.
Public engagement through education
One of the most significant aspects of the congress was the free public educational session titled ‘Understanding Neuromodulation of the Brain and Spinal Cord’. This session aimed at patients, their families, and friends, covering conditions such as chronic pain, Parkinson’s disease, and tremors. It allowed the public to engage directly with leading scientists and innovators in the field.
Innovation and recognition
The congress also featured an Innovation Day and a Non-Invasive Brain Stimulation programme. The INS honoured Dr Giancarlo Barolat with the Giant of Neuromodulation Award for his pioneering work in treating chronic pain and spasticity. Dr. Fabian Piedimonte received the newly instituted champion of the INS Award for his efforts in promoting neuromodulation education and therapy access in Latin America.
Additionally, the event included the inaugural NeuroRun, a morning run aimed at fostering well-being and informal networking among participants. This activity, introduced by the Kenes Group, was welcomed by the INS community and is expected to become a regular feature in future congresses.
The INS community is already looking forward to future gatherings. The 4th Joint Congress of the INS European Chapters (eINS 2025) will take place in Istanbul 22-24 May 2025, followed by the 17th World Congress in Lisbon, Portugal, 9-14 May 2026. These events promise to continue fostering international collaboration and scientific excellence.
